JMJD3-deficient impair CD4 T cell trafficking in autoimmune disease models and adoptive immunotherapy models by targeting cytoskeleton genes
Chuntang Fu(University of Southern California), Rong‐Fu Wang(Houston Methodist), Tianhao Duan(University of Southern California), Xin Liu(Wannan Medical College), Bingnan Yin(University of Southern California), Changsheng Xing(University of Southern California), Junjun Chu(Anhui University of Traditional Chinese Medicine)
Cited by 0
Related Papers
Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity
|Frontiers in Immunology|2022|880
Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis
|Journal of Neuroinflammation|2019|746
CD28 and CD3 have complementary roles in T-cell traction forces
|Proceedings of the National Academy of Sciences|2014|250
Tetherin Suppresses Type I Interferon Signaling by Targeting MAVS for NDP52-Mediated Selective Autophagic Degradation in Human Cells
|Molecular Cell|2017|207
USP3 inhibits type I interferon signaling by deubiquitinating RIG-I-like receptors
|Cell Research|2013|174